ArticleMolecular and clinical oncology2020

Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastoma.

K Grace Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.